Physicochemical properties of phosphorothioate oligodeoxynucleotides. - Wikidata - awgldk - TriplyDB

Physicochemical properties of phosphorothioate oligodeoxynucleotides.

Physicochemical properties of phosphorothioate oligodeoxynucleotides.

http://www.wikidata.org/entity/Q36000544

about

Improved targeting of miRNA with antisense oligonucleotides New, stronger nucleophiles for nucleic acid-templated chemistry: Synthesis and application in fluorescence detection of cellular RNA Design and application of multifunctional DNA nanocarriers for therapeutic delivery Antisense oligonucleotides: treating neurodegeneration at the level of RNA Structural Basis of the RNase H1 Activity on Stereo Regular Borano Phosphonate DNA/RNA Hybrids Inhibition of human immunodeficiency virus activity by phosphorodithioate oligodeoxycytidine Antisense down-regulation of thymidylate synthase to suppress growth and enhance cytotoxicity of 5-FUdR, 5-FU and Tomudex in HeLa cells Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma The experimental use of antisense oligonucleotides: a guide for the perplexed Phosphoroselenoate oligodeoxynucleotides: synthesis, physico-chemical characterization, anti-sense inhibitory properties and anti-HIV activity Antisense-induced down-regulation of thymidylate synthase and enhanced cytotoxicity of 5-FUdR in 5-FUdR-resistant HeLa cells Solid-Phase Supports for Oligonucleotide Synthesis Immunization with a hemagglutinin-derived synthetic peptide formulated with a CpG-DNA-liposome complex induced protection against lethal influenza virus infection in mice.The stability, toxicity and effectiveness of unmodified and phosphorothioate antisense oligodeoxynucleotides in Xenopus oocytes and embryos.Inhibition of gene expression by anti-sense C-5 propyne oligonucleotides detected by a reporter enzyme Triple-helix formation by alpha oligodeoxynucleotides and alpha oligodeoxynucleotide-intercalator conjugates.Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus Targeted elimination of zygotic messages in Xenopus laevis embryos by modified oligonucleotides possessing terminal cationic linkages.Design and evaluation of locked nucleic acid-based splice-switching oligonucleotides in vitro.Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A.Production of antibodies with peptide-CpG-DNA-liposome complex without carriers.Newly designed six-membered azasugar nucleotide-containing phosphorothioate oligonucleotides as potent human immunodeficiency virus type 1 inhibitors.Treatment with a toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB/W mice.Oligonucleotides antisense to the interleukin 1 receptor mRNA block the effects of interleukin 1 in cultured murine and human fibroblasts and in mice.Fully modified 2' MOE oligonucleotides redirect polyadenylation Improving lambda red genome engineering in Escherichia coli via rational removal of endogenous nucleases.Gene suppression strategies for dominantly inherited neurodegenerative diseases: lessons from Huntington's disease and spinocerebellar ataxia.Inhibition of the erbB-2 tyrosine kinase receptor in breast cancer cells by phosphoromonothioate and phosphorodithioate antisense oligonucleotides.Early development of the Toll-like receptor 9 agonist, PF-3512676, for the treatment of patients with advanced cancers.Oligonucleotides with conjugated dihydropyrroloindole tripeptides: base composition and backbone effects on hybridization.Optimal oligonucleotide sequences for TLR9 inhibitory activity in human cells: lack of correlation with TLR9 binding 5'-Cholesteryl-phosphorothioate oligodeoxynucleotides: potent inhibition of methotrexate transport and antagonism of methotrexate toxicity in cells containing the reduced-folate carrier.Stability and functional effectiveness of phosphorothioate modified duplex DNA and synthetic 'mini-genes'.An exonuclease-amplification coupled capture technique improves detection of PCR product In vivo stability and kinetics of absorption and disposition of 3' phosphopropyl amine oligonucleotides Differential distribution of oligodeoxynucleotides in developing organs with epithelial-mesenchymal interactions Targeting c-Myb expression in human disease.Comparative inhibition of rabbit globin mRNA translation by modified antisense oligodeoxynucleotides Inhibition of herpes simplex virus type 2 growth by phosphorothioate oligodeoxynucleotides.Design and Structural Requirements of the Potent and Safe TLR-9 Agonistic Immunomodulator MGN1703.

P2860

Q24547511-CDE7D122-AF55-498E-8EAD-5BFED2F01030 Q24655496-28E1D3FC-5089-4EC0-B763-DB3002A5675C Q27007011-A0ECA5E7-6F39-47AD-963F-C3482C4DE624 Q27007056-E53034EA-EECB-489B-A7C8-E8C3501B82BD Q27667339-EB07D447-2E13-4BA2-A63D-09754D415B63 Q28316278-0B82541B-7D13-4C8B-AF3B-D285278CF16B Q28343570-9E7695ED-AA12-463F-BFF3-1805ADC678A3 Q28345950-062AA11D-37D6-48BE-A2C9-62FF384FE1C9 Q28349648-CBE8B8FF-9660-459D-BAAE-93841D3EA9DF Q28355095-50AC088F-90D6-47B5-9D41-40F8AD79D435 Q28365365-DFC74C6B-8697-414C-B0C9-F6088CD0962D Q29999315-8E39B9BF-0DE7-4ABA-A68E-2CB8180AA066 Q30423481-B1EEA3F5-A29E-4020-AFF9-ACD5630F8AFA Q30450778-28E2EA9A-EB93-4D48-AEE9-8EA633E15E34 Q30673942-87668A1D-DFDF-425E-9686-9B879E81E6F2 Q33648095-AB8A30C2-02D0-4942-8F12-20B8A896B0F3 Q33650315-67B7DED3-3580-4EF2-B022-A288FD2F5ECF Q33688988-6EE2143F-AE8C-430D-B56E-4F2411130FBB Q33843195-99A9B970-FA96-4383-8C1F-21D25C8BB905 Q33851819-4DB53788-79B1-49E0-8377-5D802B4D3766 Q33904706-A72C2A49-1A55-476E-98A8-39455BCFDB7F Q34076980-95551BA0-2DA0-47E0-A96C-48824E212A7A Q34114826-CF33C767-863A-4FCB-9873-2B4C3A44106F Q34204201-608BAB40-75F2-4B0D-93ED-90ED5364EBBD Q34281915-63FC585C-9E10-401E-9436-BBC7FFEEC217 Q34408253-105E6B44-FF22-4828-BA49-552BAE047F3B Q34499502-DE804A0C-4A43-47A6-B95C-E2138EF754B0 Q34618574-AC900694-7EFF-4864-9778-0C47A41E7C87 Q34619324-87064C9C-4626-4199-9396-C7F52CF9A407 Q34636286-D9A6026C-B99F-4A1D-B7AE-50CD41EB858A Q34647633-B5CE32A8-8659-4D69-8E70-F9FAFA7A6C8E Q34772710-652B6866-7573-4797-A470-AE99C3A9B86D Q34776973-7B380ECE-67EA-41B4-A651-413A18CCE4F2 Q34996776-19C50BD7-E810-47EF-9110-7162850AF483 Q35012323-C1AFEE2A-D3E1-43D3-A74E-C7C26F97370E Q35042688-DF687A73-1A4E-465D-800E-C18595FD98B9 Q35095153-65190CDB-2AB8-4916-A805-BE91353D277D Q35230003-1FACBDE8-F19C-472E-8194-D267ED9667B7 Q35253635-ECEFD966-20CB-4C8B-B9AA-98E93E0F2AC3 Q35635250-D80C0760-25DC-4EE7-A218-7392272606E3

P2860

Physicochemical properties of phosphorothioate oligodeoxynucleotides.

http://www.wikidata.org/entity/Q36000544

description

1988 nî lūn-bûn

@nan

1988年の論文

@ja

1988年論文

@yue

1988年論文

@zh-hant

1988年論文

@zh-hk

1988年論文

@zh-mo

1988年論文

@zh-tw

1988年论文

@wuu

1988年论文

@zh

1988年论文

@zh-cn

name

Physicochemical properties of phosphorothioate oligodeoxynucleotides.

@ast

Physicochemical properties of phosphorothioate oligodeoxynucleotides.

@en

type

label

Physicochemical properties of phosphorothioate oligodeoxynucleotides.

@ast

Physicochemical properties of phosphorothioate oligodeoxynucleotides.

@en

prefLabel

Physicochemical properties of phosphorothioate oligodeoxynucleotides.

@ast

Physicochemical properties of phosphorothioate oligodeoxynucleotides.

@en

P1433

Q36000544-4CA7FE32-72F8-44AD-98D6-AF5C2FB6D92A

P1476

Q36000544-9078E77F-7C22-4DB2-879E-F19A7EC8A94A

P2093

Q36000544-1D4DA69B-EB59-424C-A9DE-6B05F8825C48

Q36000544-444209FE-DB88-48E9-A0D4-1A0C87E7D13E

Q36000544-C0CB1ECD-598C-48D4-946E-35B93C690EEE

Q36000544-D989DB27-E376-4146-B91C-82C9E4477DA8

P2860

Q36000544-10A9111E-914B-4A05-B3C0-4F0F2895604E

Q36000544-2B8B343C-C0F1-4D12-9FFF-CAC913717003

Q36000544-39119AA7-A651-433C-BF0C-3C3FF003C376

Q36000544-4BEE3247-341A-44D1-8F1B-3DB08DFEDEF3

Q36000544-5B5AE401-FAAB-4F42-8F5C-E957D1315DAE

Q36000544-5EB53906-1E53-410C-A585-EEF4212559AE

Q36000544-7070C631-2D87-47AA-A68F-D7D9E10BF4D9

Q36000544-832C8A61-FDB3-42C7-A86B-37F2A94297F5

Q36000544-AF3824FF-3AEF-4052-9E85-70BFD5056B25

Q36000544-F508171F-DF13-4400-BAB5-C45EF7D47D5C

P304

Q36000544-2002454F-8D3A-4AC1-90DF-E3DA0E0AE95F

P31

Q36000544-B8D3FA43-E2F4-4860-96D2-ED8354653054

P356

Q36000544-C9BBB910-048F-4639-B0DB-D9D9446B67F9

P407

Q36000544-B2B7F838-E198-4D34-BDE1-CD2FE8E14230

P433

Q36000544-2BC3209A-1AC1-410D-BC6D-CBEA7ECEC802

P478

Q36000544-3E5A8129-3F43-4731-B45B-CB54D5374E4B

P577

Q36000544-DA51E886-12DE-4500-881F-070249DAFEFA

P5875

Q36000544-88105B47-1674-4F6A-8AA7-A7C003340281

P698

Q36000544-193C477D-D23D-4BBA-9C13-28590252D7E7

P932

Q36000544-5BEE85CD-BD06-44F0-863E-AB90DC192C48

P356

P1433

Nucleic Acids Research

P1476

Physicochemical properties of phosphorothioate oligodeoxynucleotides.

@en

P2093

C A Stein

http://www.w3.org/2001/XMLSchema#string

C Subasinghe

http://www.w3.org/2001/XMLSchema#string

J S Cohen

http://www.w3.org/2001/XMLSchema#string

K Shinozuka

http://www.w3.org/2001/XMLSchema#string

P2860

Stereochemical course of the reaction catalyzed by 5'-nucleotide phosphodiesterase from snake venom

Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus

Conformational transitions of synthetic DNA sequences with inserted bases, related to the dodecamer d(CGCGAATTCGCG).

Phosphorothioate-modified oligodeoxyribonucleotides. III. NMR and UV spectroscopic studies of the Rp-Rp, Sp-Sp, and Rp-Sp duplexes, [d(GGSAATTCC)]2, derived from diastereomeric O-ethyl phosphorothioates

Nucleoside phosphorothioates.

Inhibition of rabbit globin mRNA translation by sequence-specific oligodeoxyribonucleotides.

Characterization of sequence-specific oligodeoxyribonucleoside methylphosphonates and their interaction with rabbit globin mRNA.

Biochemical and biological effects of nonionic nucleic acid methylphosphonates.

Stereochemistry of hydrolysis by snake venom phosphodiesterase.

Crystal and molecular structure of adenosine 5'-O-phosphorothioate O-p-nitrophenyl ester (Sp diastereomer). Substrate stereospecificity of snake venom phosphodiesterase.

P304

3209-3221

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NAR/16.8.3209

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

1988-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

238809055

http://www.w3.org/2001/XMLSchema#string

P698

2836790

http://www.w3.org/2001/XMLSchema#string

P932

336489

http://www.w3.org/2001/XMLSchema#string